-
Healthcare
-

NHS England Faces Fresh Probe Over Authorship of Data Platform Case Studies

By
Distilled Post Editorial Team

The Office for Statistics Regulation has opened a new investigation into NHS England, this time over who actually wrote the glowing accounts of its Federated Data Platform that have circulated as evidence of the system's success. The trigger came from an unlikely source: a small NHS trust in Cumbria that, when asked directly, admitted it had not written its own case study at all.

North Cumbria Integrated Care NHS Foundation Trust responded to a Freedom of Information request from the campaign group MedConfidential by confirming that the first draft of its case study, one that credited the platform with transforming how the trust manages patient tracking lists, was prepared by NHS England itself. The trust's account of its own involvement was modest. It described offering only minor typographical comments on what it regarded as a working document, with the substantive text remaining in NHS England's hands for what the trust called collation and further development. That is a markedly different picture from a document presented publicly as a frontline endorsement.

This is not the first time the OSR has looked at how NHS England talks about the Federated Data Platform. An investigation in July 2026 examined the use of unverified performance figures to promote the system, and in response NHS England gave a specific undertaking: it would state clearly on its website that FDP case studies were written by the organisations using the platform themselves and were neither authored nor verified centrally. The North Cumbria disclosure sits awkwardly against that commitment. If the promise was that trusts write their own stories, a document drafted centrally and lightly amended locally is difficult to square with it.

The content of the disputed case study matters as much as its authorship. It claims that before adopting the platform's referral tool, North Cumbria could track only 35 per cent of its patient tracking list, and that it can now validate the full list within a twelve-week cycle. These are the kind of figures that get quoted in ministerial briefings and used to justify further rollout, and their credibility depends entirely on where they came from and how rigorously they were checked. A statistic drafted by the body with an interest in the platform's success is not automatically wrong, but it is not independent evidence either, and treating it as such blurs a distinction the OSR exists to protect.

The stakes extend well beyond one trust in Cumbria. The Federated Data Platform, built with the American firm Palantir under a contract worth roughly £330 million, has already drawn scrutiny over privacy, procurement and the wisdom of concentrating so much NHS data infrastructure with a single external provider. Public confidence in that arrangement rests partly on the belief that reported benefits are genuine and independently arrived at. MedConfidential's FOI requests to the other trusts featured in NHS England's case study collection found a similar pattern of reticence: at least two of the remaining ten declined to answer questions about who wrote their material, referring the campaigners back to NHS England.

For NHS leaders and for the life sciences and health-tech firms watching the platform's progress, the episode is a reminder that data transparency is not a peripheral compliance matter but a condition of legitimacy for large-scale digital reform. Ministers keen to demonstrate that NHS technology investment delivers results have an incentive to see success stories multiply. That incentive is precisely why independent verification matters, and why a regulator built to police the honesty of public statistics has now had cause to look twice at the same programme within a matter of months.

The OSR is now assessing whether NHS England's conduct breaches the code of practice for statistics, which rests on the principle that official claims should be trustworthy, high quality and communicated honestly. Whatever it concludes, the case has already illustrated how easily the language of local success can be manufactured at the centre, and how hard that is to spot until someone simply asks.